Correlation Between Verastem and Cellectar Biosciences
Can any of the company-specific risk be diversified away by investing in both Verastem and Cellectar Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Verastem and Cellectar Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Verastem and Cellectar Biosciences, you can compare the effects of market volatilities on Verastem and Cellectar Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Verastem with a short position of Cellectar Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Verastem and Cellectar Biosciences.
Diversification Opportunities for Verastem and Cellectar Biosciences
-0.6 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Verastem and Cellectar is -0.6. Overlapping area represents the amount of risk that can be diversified away by holding Verastem and Cellectar Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cellectar Biosciences and Verastem is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Verastem are associated (or correlated) with Cellectar Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cellectar Biosciences has no effect on the direction of Verastem i.e., Verastem and Cellectar Biosciences go up and down completely randomly.
Pair Corralation between Verastem and Cellectar Biosciences
Given the investment horizon of 90 days Verastem is expected to generate 2.25 times more return on investment than Cellectar Biosciences. However, Verastem is 2.25 times more volatile than Cellectar Biosciences. It trades about 0.25 of its potential returns per unit of risk. Cellectar Biosciences is currently generating about -0.43 per unit of risk. If you would invest 392.00 in Verastem on September 2, 2024 and sell it today you would earn a total of 142.00 from holding Verastem or generate 36.22% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Verastem vs. Cellectar Biosciences
Performance |
| Timeline |
| Verastem |
| Cellectar Biosciences |
Verastem and Cellectar Biosciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Verastem and Cellectar Biosciences
The main advantage of trading using opposite Verastem and Cellectar Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Verastem position performs unexpectedly, Cellectar Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cellectar Biosciences will offset losses from the drop in Cellectar Biosciences' long position.The idea behind Verastem and Cellectar Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| Cellectar Biosciences vs. Monopar Therapeutics | Cellectar Biosciences vs. Pulmatrix | Cellectar Biosciences vs. Tenax Therapeutics | Cellectar Biosciences vs. Bio Path Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Other Complementary Tools
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |